major insurance changes are coming to glp 1 drugs what is the bmi requirement for GLP-1 medications transforming medical weight loss Insurance companies scrambling to support

Like Ozempic, Rybelsus is only FDA-approved to treat type 2 diabetes, but it can be prescribed off-label for weight loss

If you dont like big needles, this may improve your comfort level with giving yourself insulin injections every day

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

This issue of MIND Matters celebrates the people doing this work, including some new members of our team (p 7), the trainees who are acquiring skills and knowledge to lead this work (p 6), the progress being made by investigators (p 5), and an amazing research participant and advocate, Julie Moore (p 1 and 3) who has been recognized for her remarkable leadership